chemotherapy: be administered to lymphoma patient

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be administered to lymphoma patient 1.00
be for lymphoma determined 0.90
be for lymphoma 0.90
be administered to patient 0.89
be effective in cancer treatment 0.84
be for cancer 0.83
treat cancer 0.83
has state cancer 0.82
be just used for cancer 0.81
be for just cancer 0.81

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.56
Rule weight: 0.66
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.83
¬ Typical(chemotherapy, be administered to lymphoma patient)
0.55
Rule weight: 0.66
Evidence weight: 0.92
Similarity weight: 0.90
Evidence: 0.91
Plausible(treatment, be for lymphoma) ⋁
Evidence: 0.83
¬ Typical(chemotherapy, be administered to lymphoma patient)
0.49
Rule weight: 0.66
Evidence weight: 0.87
Similarity weight: 0.84
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.83
¬ Typical(chemotherapy, be administered to lymphoma patient)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.82
Similarity weight: 0.90
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.91
¬ Plausible(treatment, be for lymphoma)
0.07
Rule weight: 0.09
Evidence weight: 0.81
Similarity weight: 0.90
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.93
¬ Plausible(treatment, be for lymphoma determined)
0.07
Rule weight: 0.09
Evidence weight: 0.83
Similarity weight: 0.84
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.85
¬ Plausible(agent, be effective in cancer treatment)

Remarkability exclusitivity betweem a parent and a child

0.34
Rule weight: 0.58
Evidence weight: 0.71
Similarity weight: 0.84
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment)
0.34
Rule weight: 0.58
Evidence weight: 0.66
Similarity weight: 0.90
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma)
0.34
Rule weight: 0.58
Evidence weight: 0.66
Similarity weight: 0.90
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined)

Remarkability exclusitivity between siblings

0.07
Rule weight: 0.13
Evidence weight: 0.60
Similarity weight: 0.83
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.58
¬ Remarkable(gene therapy, treat cancer)
0.05
Rule weight: 0.13
Evidence weight: 0.45
Similarity weight: 0.89
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.81
¬ Remarkable(gene therapy, be administered to patient)
0.05
Rule weight: 0.13
Evidence weight: 0.42
Similarity weight: 0.82
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.86
¬ Remarkable(breast cancer, has state cancer)

Remarkability from parent implausibility

0.37
Rule weight: 0.42
Evidence weight: 0.98
Similarity weight: 0.90
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.68
Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.80
¬ Plausible(chemotherapy, be administered to lymphoma patient)
0.37
Rule weight: 0.42
Evidence weight: 0.98
Similarity weight: 0.90
Evidence: 0.91
Plausible(treatment, be for lymphoma) ⋁
Evidence: 0.68
Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.80
¬ Plausible(chemotherapy, be administered to lymphoma patient)
0.34
Rule weight: 0.42
Evidence weight: 0.96
Similarity weight: 0.84
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.68
Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.80
¬ Plausible(chemotherapy, be administered to lymphoma patient)

Remarkability from sibling implausibility

0.53
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.89
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.81
Remarkable(gene therapy, be administered to patient) ⋁
Evidence: 0.38
¬ Plausible(gene therapy, be administered to patient)
0.49
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.82
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.86
Remarkable(breast cancer, has state cancer) ⋁
Evidence: 0.32
¬ Plausible(breast cancer, has state cancer)
0.46
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.83
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.58
Remarkable(gene therapy, treat cancer) ⋁
Evidence: 0.84
¬ Plausible(gene therapy, treat cancer)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.88
¬ Salient(chemotherapy, be administered to lymphoma patient)

Similarity expansion

0.65
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.83
Evidence: 0.83
Typical(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.52
¬ Typical(chemotherapy, be for cancer)
0.64
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.83
Evidence: 0.88
Salient(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.81
¬ Salient(chemotherapy, be for cancer)
0.62
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.83
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.61
¬ Plausible(chemotherapy, be for cancer)
0.62
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.81
Evidence: 0.88
Salient(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.89
¬ Salient(chemotherapy, be just used for cancer)
0.61
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.81
Evidence: 0.88
Salient(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.94
¬ Salient(chemotherapy, be for just cancer)
0.61
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.81
Evidence: 0.83
Typical(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.68
¬ Typical(chemotherapy, be just used for cancer)
0.59
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.81
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.73
¬ Plausible(chemotherapy, be just used for cancer)
0.58
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.81
Evidence: 0.83
Typical(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.90
¬ Typical(chemotherapy, be for just cancer)
0.57
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.81
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.87
¬ Plausible(chemotherapy, be for just cancer)
0.54
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.81
Evidence: 0.68
Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
0.51
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.83
Evidence: 0.68
Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
0.51
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.81
Evidence: 0.68
Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.81
¬ Remarkable(chemotherapy, be just used for cancer)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.88
Salient(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.83
¬ Typical(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient)

Typical implies Plausible

0.40
Rule weight: 0.48
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.80
Plausible(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.83
¬ Typical(chemotherapy, be administered to lymphoma patient)

Typicality and Rermarkability incompatibility between a parent and a child

0.16
Rule weight: 0.51
Evidence weight: 0.35
Similarity weight: 0.90
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.96
¬ Typical(treatment, be for lymphoma)
0.16
Rule weight: 0.51
Evidence weight: 0.34
Similarity weight: 0.90
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.98
¬ Typical(treatment, be for lymphoma determined)
0.16
Rule weight: 0.51
Evidence weight: 0.36
Similarity weight: 0.84
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.82
Similarity weight: 0.89
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.27
¬ Typical(gene therapy, be administered to patient)
0.10
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 0.82
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.17
¬ Typical(breast cancer, has state cancer)
0.04
Rule weight: 0.14
Evidence weight: 0.40
Similarity weight: 0.83
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.89
¬ Typical(gene therapy, treat cancer)

Typicality inheritance from parent to child

0.36
Rule weight: 0.48
Evidence weight: 0.83
Similarity weight: 0.90
Evidence: 0.83
Typical(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.96
¬ Typical(treatment, be for lymphoma)
0.36
Rule weight: 0.48
Evidence weight: 0.83
Similarity weight: 0.90
Evidence: 0.83
Typical(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.98
¬ Typical(treatment, be for lymphoma determined)
0.34
Rule weight: 0.48
Evidence weight: 0.84
Similarity weight: 0.84
Evidence: 0.83
Typical(chemotherapy, be administered to lymphoma patient) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)